Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov…

Overview of attention for article published in Drug Design, Development and Therapy, January 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 583 followers.

Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Mo | DDDT https://t.co/zGHNM4Yh0S

Reply Repost Favourite